[go: up one dir, main page]

ES2147399T3 - Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica. - Google Patents

Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.

Info

Publication number
ES2147399T3
ES2147399T3 ES96939987T ES96939987T ES2147399T3 ES 2147399 T3 ES2147399 T3 ES 2147399T3 ES 96939987 T ES96939987 T ES 96939987T ES 96939987 T ES96939987 T ES 96939987T ES 2147399 T3 ES2147399 T3 ES 2147399T3
Authority
ES
Spain
Prior art keywords
pct
derivatives
hidroxianilidas
trimetil
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96939987T
Other languages
English (en)
Inventor
Jean-Francois Patoiseau
Jean-Marie Autin
Andre Delhon
Philippe Oms
Didier Junquero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2147399T3 publication Critical patent/ES2147399T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE LAS 2,3,5 TRIMETIL - 4 - HIDROXI ANILIDAS DE FORMULA GENERAL (I), EN LA CUAL R 1 REPRESENTA UN FENILO, R 2 REPRESENTA H, R SU B,3 REPRESENTA C 12 H 25 Y A ES UN ATOMO DE AZUFRE. SE REFIERE TAMBIEN A SU METODO DE PREPARACION Y A LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN COMO PRINCIPIO ACTIVO AL MENOS UNO DE ESTOS COMPUESTOS, ASI COMO A LA UTILIZACION DE SUS DERIVADOS PARA LA FABRICACION DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO DE LA HIPERCOLESTEROLEMIA Y LA ATEROSCLEROSIS.
ES96939987T 1995-11-28 1996-11-27 Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica. Expired - Lifetime ES2147399T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514086A FR2741619B1 (fr) 1995-11-28 1995-11-28 Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ES2147399T3 true ES2147399T3 (es) 2000-09-01

Family

ID=9484963

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96939987T Expired - Lifetime ES2147399T3 (es) 1995-11-28 1996-11-27 Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.

Country Status (18)

Country Link
US (1) US5990173A (es)
EP (1) EP0874812B1 (es)
JP (1) JP2000500771A (es)
KR (1) KR100417275B1 (es)
CN (1) CN1072645C (es)
AT (1) ATE191473T1 (es)
AU (1) AU701186B2 (es)
BR (1) BR9611790A (es)
CA (1) CA2238845C (es)
DE (1) DE69607650T2 (es)
DK (1) DK0874812T3 (es)
ES (1) ES2147399T3 (es)
FR (1) FR2741619B1 (es)
GR (1) GR3033786T3 (es)
MX (1) MX9804226A (es)
NZ (1) NZ322959A (es)
PT (1) PT874812E (es)
WO (1) WO1997019918A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823207B1 (fr) * 2001-04-10 2004-12-03 Pf Medicament Complexes d'anilides a chaine polycarbonee et de cyclodestrines, leur preparation et leur application en tant que medicamment en particulier pour le traitement des dislipidemies
HUP0401696A2 (hu) * 2001-08-28 2004-11-29 Sankyo Co., Ltd. Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény
FR2830761B1 (fr) * 2001-10-12 2003-12-12 Pf Medicament Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique
FR2830760B1 (fr) * 2001-10-12 2004-06-04 Pf Medicament Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
FR2845991B1 (fr) * 2002-10-16 2005-02-04 Pf Medicament Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
US20060247458A1 (en) * 2003-02-28 2006-11-02 Shogo Yamamoto Process for the production of optically active compounds having substituents at the 2-position
FR2854079B1 (fr) 2003-04-25 2007-11-30 Pf Medicament Procede de preparation de complexes moleculaires
AU2004242777B2 (en) 2003-05-30 2011-05-12 Ranbaxy Laboratories Limited Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
US7923573B2 (en) * 2004-10-27 2011-04-12 Daiichi Sankyo Company, Limited Benzene compound having 2 or more substituents
KR101329112B1 (ko) 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
FR2918889B1 (fr) * 2007-07-19 2009-10-23 Galderma Res & Dev Utilisation de l'eflucimibe pour la preparation d'un medicament destine a prevenir ou a traiter une maladie due a un dysfonctionnement des glandes sebacees chez l'homme ou l'animal
WO2009061208A1 (en) 2007-11-09 2009-05-14 Pronova Biopharma Norge As Lipid compounds for use in cosmetic products, as food supplement or as a medicament
CN101450911B (zh) * 2007-11-30 2012-02-29 山东轩竹医药科技有限公司 被金刚烷取代的苯甲酸衍生物
EP2147910A1 (en) * 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
JP5843755B2 (ja) 2009-05-08 2016-01-13 プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸
EP2248798A1 (en) * 2009-05-08 2010-11-10 Pronova BioPharma Norge AS Novel lipid compounds
PH12013500893A1 (en) 2010-11-05 2013-07-15 Pronova Biopharma Norge As Methods of treatment using lipid compounds
FR2973374B1 (fr) * 2011-04-04 2013-08-23 Pf Medicament Nouveaux alkylthioethers, leur preparation et leur application en therapeutique
ES2748562T3 (es) 2013-02-28 2020-03-17 Basf As Una composición que comprende un compuesto lipídico, un triglicérido y un tensioactivo, y procedimientos de uso de la misma
CA2983377C (en) 2015-04-28 2023-08-29 Pronova Biopharma Norge As Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
SG11202005007VA (en) 2017-12-06 2020-06-29 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6040898A (ja) * 1983-03-31 1985-03-04 Suzuki Shiyoukan:Kk 真空断熱容器或は貯蔵の製作方法
KR0169501B1 (ko) * 1990-11-26 1999-03-20 우에하라 아키라 아닐리드 유도체
FR2673625B1 (fr) * 1991-03-08 1993-05-07 Adir Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993013086A1 (en) * 1991-12-25 1993-07-08 Taisho Pharmaceutical Co., Ltd. Anilide derivative
JP2842147B2 (ja) * 1992-05-26 1998-12-24 大正製薬株式会社 Ａｃａｔ阻害剤

Also Published As

Publication number Publication date
CA2238845C (fr) 2006-08-29
CA2238845A1 (fr) 1997-06-05
CN1072645C (zh) 2001-10-10
KR19990071679A (ko) 1999-09-27
BR9611790A (pt) 1999-07-13
GR3033786T3 (en) 2000-10-31
DE69607650D1 (de) 2000-05-11
AU7700096A (en) 1997-06-19
DK0874812T3 (da) 2000-09-11
MX9804226A (es) 1998-09-30
NZ322959A (en) 2001-05-25
DE69607650T2 (de) 2000-11-30
PT874812E (pt) 2000-09-29
EP0874812B1 (fr) 2000-04-05
ATE191473T1 (de) 2000-04-15
KR100417275B1 (ko) 2004-05-20
EP0874812A1 (fr) 1998-11-04
FR2741619B1 (fr) 1998-02-13
US5990173A (en) 1999-11-23
FR2741619A1 (fr) 1997-05-30
CN1205689A (zh) 1999-01-20
JP2000500771A (ja) 2000-01-25
AU701186B2 (en) 1999-01-21
WO1997019918A1 (fr) 1997-06-05

Similar Documents

Publication Publication Date Title
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
TR200001816T2 (tr) Hipolipidemik benzotiyazepin bileşikleri
NZ337118A (en) 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same useful in treating or preventing arteriosclerotic and/or hyper-lipemia disease, pancreatitis, obesity, hypercholesterolemia and hypertriglyceridemia.
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
PT91575A (pt) Procede de preparation de benzylamines disubstituees utiles comme medicaments
DE69719511D1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
HK1028028A1 (en) Substituted heterocyclic compounds, method for preparing and compositions containing same
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
SE8904127D0 (sv) New biocyclic amino-substituted compounds
YU6996A (sh) Upotreba benzotiofena za dobijanje leka
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 874812

Country of ref document: ES